Analyst David Amsellem works at PIPER SANDLER and is focused on the Healthcare sector with 611 price targets and ratings documented since 2009 spanning on 28 stocks. Analyst's average stock valuation to be materialised ratio is 59.45% with an average time for price targets to be met of 277.19 days.
Most recent stock forecast was given on VTRS, at 08-Nov-2022.
David Amsellem best performing recommendations are on OGN.
The best stock recommendation documented was for NBIX (NEUROCRINE BIOSCIENCES, INC) at 12/19/2013. The price target of $17 was fulfilled within 19 days with a profit of $7.88 (86.4%) receiving and performance score of 45.48.
Average potential price target upside